In support of improving patient care, The Robert Larner, M.D. College of Medicine at the University of Vermont is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Vermont designates this live activity for a maximum of 6.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program has been reviewed and is acceptable for up to 6.25Nursing Contact Hours
The Robert Larner College of Medicine at the University of Vermont has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
This program was planned by and for the healthcare team, and learners will receive 6.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Meeting Disclaimer: Regarding materials and information received during this educational event, the views, statements, and recommendations expressed during this activity represent those of the authors and speakers and do not necessarily represent the views of the University of Vermont.
Relevant Financial Relationships:* All those with control of content (speakers, planners, moderators, reviewers, staff) who have relevant financial relationships with “ineligible companies” are listed below. (An “ineligible company” is defined as one whose primary business is producing, marketing, selling, reselling or distributing healthcare products used by or on patients.)
Nick Cheney, PhD – Biobe, Inc. – Co-founder
Mondira Ray, MD – OpenEvidence – Full-time employee
The speakers above are experts sharing educational insights on safe AI use and are not endorsing any products or making clinical recommendations.
No other speakers, planners or CMIE reviewers have any relevant financial relationships with ineligible companies.
Support Received from Ineligible Companies:
We have not received any support from Ineligible Companies
*Having a financial relationship with an ineligible company, or discussing an unlabeled use of product, may not prevent a speaker from making a presentation. However, the existence of the relationship must be made known to the planning committee prior to the conference, so that any relevant financial interest may be mitigated prior to the talk.
Learners are advised that accredited status does not imply endorsement by the provider of any commercial products displayed in conjunction with an activity.